Recode Studios IPO Final Day: GMP ₹38 (+₹1)

Welcome back to our daily IPO update! Today marks the final day of the Recode Studios SME IPO subscription period, and we’re diving deep into the numbers as the market closes. As of the end of Day 3, the subscription figures are still showing zero across all categories – Retail, NII, and QIB. This is certainly an unusual situation for a closing day, and it definitely warrants a closer look at what it might mean for potential investors. The IPO, which opened on May 5th and closes today, May 7th, 2026, has its issue price fixed at ₹158 per share. Let’s break down what these numbers, or rather the lack thereof, tell us.

Subscription Status

The subscription status for Recode Studios IPO is, to put it mildly, intriguing. We’re seeing 0x subscribed across Retail, NII (Non-Institutional Investors), and QIB (Qualified Institutional Buyers) categories. Typically, by the closing day, especially for an SME IPO, you’d expect to see some traction, even if it’s modest. The fact that there are no subscriptions yet is quite a departure from the usual pattern. For Retail investors, this could mean a few things. It might indicate a wait-and-watch approach, perhaps waiting for last-minute rushes or more concrete market sentiment. For NII and QIB investors, who often subscribe to larger portions, this zero could signal caution or a reassessment of their investment thesis for Recode Studios. It’s unusual for all categories to remain at zero until the very last moment. We’ll be watching closely for any late-day filings, but as it stands, the demand hasn’t materialized yet.

GMP Update

Now, let’s talk about the Grey Market Premium (GMP). Interestingly, despite the lack of subscription numbers, the GMP for Recode Studios IPO has seen a slight uptick. Yesterday, it was hovering around ₹37, and today it’s reported at ₹38, a ₹1 increase. This is encouraging, as it suggests that the market sentiment, at least in the unofficial grey market, remains positive. With the issue price at ₹158, a GMP of ₹38 points towards an expected listing price of ₹196 (₹158 + ₹38). This ₹196 expected listing price is a significant premium over the issue price, which is often a key driver for IPO applications. The increase, however small, shows continued interest and perhaps a belief in the company’s future prospects, even if it hasn’t translated into formal subscriptions yet.

Should You Apply?

This is the million-dollar question, isn’t it? We have a situation where the GMP is showing a positive outlook with an expected listing gain, but the subscription numbers are completely absent on the closing day. This is a classic dilemma. On one hand, the GMP suggests that if the trend holds, investors could see a decent return on listing day. The expected listing price of ₹196 is certainly attractive. However, the lack of subscriptions is a red flag that can’t be ignored. It raises questions about investor confidence, the company’s market positioning, or perhaps even external market factors influencing investment decisions. SEBI advisors often recommend looking at both subscription levels and GMP, alongside the company’s fundamentals. Given the current data, it’s a high-risk, potentially high-reward scenario. If you’re a risk-tolerant investor who believes in the long-term prospects of Recode Studios and is comfortable with the current GMP trend, you might consider applying, especially if you anticipate a last-minute surge in subscriptions. That said, exercising caution and perhaps waiting for the final subscription data before making a decision would also be a prudent approach. The lot size is 800 shares. For more detailed information on the IPO, you can View Full Recode Studios IPO Details.